Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

TIE Kinetix Reports Q3 Trading Update FY 2021

EBITDA increases to 19% on flat revenueTIE Kinetix, the leading provider of software as a service (SaaS) managed solutions for supply chain digitization with EDI, announces its trading update for the third quarter of 2021 today. (€ * 1000) Q3 Q3 Variance YTD Q3 YTD Q3 Variance (%) 2021 2020* (%) 2021 2020*Total 3,754 3,935 -4.6% 11,177 11,116 +0.5%RevenuesOf which: 2,409 2,260 +6.6% 7.124 6,278 +13.5%SaaS RevenuesEBITDA 541 341 +58.6% 2,140 1,440 +48.6%* Q3 2020 andYTD Q3 2020

Metso Outotec’s Half-Year Report January 1 – June 30, 2021

Metso Outotec Corporation’s stock exchange release on August 4, 2021, at 09:00 a.m. EESTMetso Outotec has prepared both illustrative and IFRS-based historical segment information for January-June 2020, prior to the merger of Metso Minerals and Outotec. The illustrative combined historical information is presented as a combination of Metso Minerals carve-out information and Outotec information, according to the Metso Outotec structure. Figures in brackets refer to the corresponding period in 2020, unless otherwise stated. Second quarter 2021 in brief, IFRS (comparison period

Raisio plc’s Half-Year Financial Report January − June 2021

Raisio plc’s Half-Year Financial Report, 4 August 2021 at 8:30 a.m. Finnish timeOn the Verge of a New Growth FINANCIAL DEVELOPMENT IN BRIEF  April–June 2021 · The Group’s net sales totalled EUR 66.7 (59.9) million, which signified a growth of 11.3%. · Comparable EBIT was EUR 5.3 (7.0) million, accounting for 7.9 (11.6)% of net sales. Comparable EBIT decreased by -24.7% in relation to the comparison period. · EBIT was EUR 4.5* (7.0) million, which accounted for 6.8 (11.6)% of net sales. · The Healthy Food Segment’s net sales totalled EUR 34.7 (31.6) million. Comparable

BERGENBIO ASA: INVITATION TO PRESENTATION OF SECOND QUARTER AND HALF YEAR 2021 RESULTS

Bergen, Norway, 4 August 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, will be announcing its results for the second quarter and half year 2021 on Tuesday 17 August 2021. A webcast presentation by BerGenBio’s senior management team will take place at 10:00 am CET. The live webcast link will be available at www.bergenbio.com in the Investors/Financial Reports section. A recording will be available shortly after the webcast has finished. The second quarter report and

Filo Mining Reports 425m at 1.55% CuEq, including 4m at 5,045 g/t Silver at Filo del Sol; Extends the deposit another 750m to the North

VANCOUVER, BC, Aug. 4, 2021 /CNW/ - Filo Mining Corp. (TSXV: FIL) (Nasdaq First North Growth Market: FIL) (OTCQX: FLMMF) (“Filo Mining”, or the “Company”) is pleased to announce additional drill results from the Filo del Sol project in San Juan province, Argentina.  Highlights are listed below, along with accompanying figures: · Drillhole FSDH049 returned 425.3m at 1.55% CuEq (0.42% Cu; 0.44g/t Au; 91.5g/t Ag); included within the long intercept, was the highest-grade silver intersection on the project to date, with 4m at 5,045.0 g/t Ag from a depth of 236m contained within a broader

Nordic Nanovector Provides Update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma

Oslo, Norway, 3 August 2021 Nordic Nanovector ASA (OSE: NANOV) provides an update on the timeline for PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin[® ]([177]Lu lilotomab satetraxetan) in 3[rd]-line relapsed rituximab/anti-CD20 refractory follicular lymphoma (3L R/R FL). The Company, having reviewed the recent rate of patient recruitment in discussion with its clinical advisors and in light of the continuing impact from the COVID pandemic, now anticipates the preliminary three-month data readout from PARADIGME during the first half of 2022. The Company will host a live

Sprint Bioscience licenses the cancer drug program Vps34 to Deciphera Pharmaceuticals

Sprint Bioscience AB (publ) announces today that the company has licensed its cancer drug program Vps34 to the US pharmaceutical company Deciphera Pharmaceuticals. The license agreement covers exclusive global rights to the program. The agreement has a total potential value of up to USD 277 million, plus additional tiered percentage royalties ranging from the mid-single-digits to the low-double-digits on the sales of a future drug from the program, if approved. On signing of the agreement, Sprint Bioscience will receive an upfront payment of USD 4 million, which will be entered into the

Medicover acquire SellmerDiers sperm bank in Denmark

Medicover has acquired 88.8 per cent of the voting rights of the Danish sperm bank SellmerDiers from the two founders, Liza Diers and Anette Sellmer. SellmerDiers operates in three cities Aarhus, Copenhagen and Aalborg and is the third largest European sperm bank. SellmerDiers was acquired for 13.7 MEUR plus earn-out linked to future performance and reported revenue of 4.0 MEUR in 2020. The acquisition is an important strategic addition to Medicover’s existing fertility business.   For further information, please contact: Hanna Bjellquist, Head of Investor Relations +46 703 033

Sandvik acquires DSI Underground Joint Ventures, Rocbolt Technologies

Sandvik’s acquisition of DSI Underground, the global leader in ground support and reinforcement products, systems and solutions for the underground mining and tunneling industries, was closed on July 7, 2021. The acquisition included DSI’s ownership stake in four joint ventures (“Rocbolt Technologies”) based in China, South Africa, Mongolia and Australia.   On August 3, 2021, Sandvik signed and completed three agreements to acquire the Joint Venture partner’s (Jennmar) share of the Rocbolt Technologies JVs in China, South Africa and Mongolia. Jennmar will continue to be a JV partner in

Information about RNB's continued process of reviewing the company's future

As informed in RNB Retail and Brands AB (the “Company")'s most recent quarterly reports, the company is reviewing the possibilities of continuing as an independent listed company. This work examines several different alternatives, including acquiring complementary operations by issuing new shares or selling existing operations and acquiring new operations. The company is also investigating the possibility of carrying out a directed issue to shareholders in connection with these alternatives in order to raise new capital. However, all alternatives that enable the company's continued

#21-258 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-257 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Normet Group Oy and Hindustan Zinc Limited signed a Memorandum of Understanding (MoU) to deploy battery-powered service equipment and utility vehicle in their underground mining

Udaipur, Friday 30[th] July 2021, Hindustan Zinc Limited (HZL), represented by Mr. Arun Misra, CEO, Hindustan Zinc and, Normet Group Oy, represented by Mr. Subhasis Mohanty, Vice President, India Sales Area signed a Memorandum of Understanding (MoU) to introduce Normet SmartDrive® - a modular Battery Electric Vehicle (BEV) to Hindustan Zinc with an aim to not just bring electromobility in Hindustan Zinc operations but also lead the way for decarbonizing the future of Indian mining.Normet has a long relationship with HZL jointly working on improving safety and productivity of HZL operations.

Publication of a Prospectus

Regulatory Announcement   Royal Bank of CanadaAugust 3, 2021 Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. Royal Bank of Canada has agreed to issue GBP500,000,000 Floating Rate Senior Notes due August 2022, Series 62467 (the "Notes") pursuant to its Programme for the Issuance of Securities (the "Programme"). The following document constitutes the final terms dated August 3, 2021 (the "Final Terms") relating to the admission to trading of the Notes for purpose of Article 8 of Regulation (EU)

Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Aquaporin’s shares

Company announcement no. 18/2021 Pursuant to the Market Abuse Regulation article 19, Aquaporin A/S, CVR no. 28315694 (“Aquaporin” or the “Company”), shall hereby notify receipt of information of the following transactions made by persons discharging managerial responsibilities in Aquaporin and persons closely associated with them in Aquaporin's shares and other financial instruments linked thereto. Reference is made to the company announcement no. 10/2021 dated 28 June 2021 regarding PDMR notification for the lending of shares and no. 17/2021 regarding the end of stabilization period.

Bambuser Signs Master Agreement with LVMH Following Initial Pilot Activations and LVMH Innovation Award

Stockholm – 3 August 2021 – Bambuser today announced it has entered into a long-term master agreement with LVMH Moët Hennessy Louis Vuitton (LVMH), following successful pilot activations. The agreement will strengthen the companies' partnership following Bambuser's receipt of the LVMH Innovation Award. Bambuser has previously entered into proof-of-concept agreements with two of LVMH’s Maisons. Following the successful activations, Bambuser and LVMH have entered into a long-term master agreement that allows all LVMH’s Maisons and divisions in all markets to leverage Bambuser’s robust

Invitation to a presentation of the interim report for January – June 2021

MilDef invites investors, analysts, and media, to a digital presentation and Q&A session, on Wednesday August 4, 2021, where CEO Björn Karlsson and EVP/CFO Daniel Ljunggren introduce the company and comment on the interim report.The presentation is in English and is concluded with a Q&A session. Start time is 11:00 CEST and the meeting time is approximately 30 minutes. The interim report is published 08:00 CEST, August 4, 2021. Presentation material will be made available on www.mildef.com. Welcome! Connecting to the meeting To connect to the meeting, click this Teams link 

Getinge Joins AdvaMed, Reinforcing Global Commitment to Advancing Innovation in Medical Technology and Improving Healthcare Policy and Patient Outcomes

Wayne, NJ (August 3, 2021) – Getinge today announced that the company has joined AdvaMed, the world’s largest trade association representing medical technology manufacturers.  Membership in AdvaMed positions Getinge to continue to advance the company’s global commitment to supporting innovation and the highest standards in quality and integrity in medical technology that can improve healthcare systems and patient care around the world.“Partnership with AdvaMed is aligned to our company’s mission to deliver the highest quality solutions in medical technology based on an understanding of our

TORM plc to announce second quarter and first half 2021 results

TORM plc (“TORM” or the “Company”) (ticker: TRMD A on Nasdaq in Copenhagen and TRMD on Nasdaq in New York) will release its financial results for the second quarter and first half of 2021 on Tuesday, 10 August 2021. The Company’s results will be presented at a conference call at 09:00 am Eastern Time / 03:00 pm Central European Time. If you wish to participate in the call, please dial +45 3272 0417 (or +1 (646) 741 3167 for US connections) at least ten minutes prior to the start of the call to ensure connection and use 7166846 as conference ID. The presentation can be downloaded from

Indutrade acquires Advance Welding – British manufacturer of electrofusion welding equipment

Indutrade has on 3 August 2021 signed an agreement to acquire all of the shares in the British company Advance Technical Services Ltd (Advance Welding), advancewelding.co.uk, with annual sales of approximately GBP 4 million.Advance Welding designs and manufactures electrofusion welding equipment for utility companies in the gas, fresh water, waste water and telecoms industries. The comprehensive product range, covering pipe welding units for all PE (and PP) piping markets, is complemented by mechanical tooling products, as well as service and technical training. The large customer base is

Pihlajalinna Plc publishes Half Year Financial Report for January 1–June 30, 2021 on Friday, August 13, 2021

Pihlajalinna Plc                   Press Release                     3 August 2021 at 3.30 pm Pihlajalinna Plc publishes Half Year Financial Report for January 1–June 30, 2021 on Friday, August 13, 2021 Half Year Financial Report Pihlajalinna Plc will publish the Half Year Financial Report for the period January 1–June 30, 2021 on Friday, August 13, 2021 at 8.00 a.m. The release will be available on the company website https://investors.pihlajalinna.fi. Press and analyst meeting A meeting for analysts and the press, conducted in Finnish, will be held on Friday, August 13,

Invitation to Nokian Tyres’ Capital Markets Day on September 9, 2021

Nokian Tyres plc Press Release August 3, 2021 at 2:05 p.m. Nokian Tyres invites analysts and investors to its virtual Capital Markets Day 2021 on Thursday, September 9, 2021. The event focuses on the company’s mid-term growth ambition and how the business units and areas contribute to the growth. Agenda (Finnish time): 1:00 p.m. Opening of CMD · CEO Jukka Moisio · CFO Teemu Kangas-Kärki · Russia, EVP Andrei Pantioukhov · North America, Nordics & Vianor, EVP Anna Hyvönen · Central Europe, EVP Bahri Kurter · Heavy Tyres, EVP Manu Salmi 4:15 p.m. (estimated)

There are no items matching the current filter
There are no more items matching the current filter
Back to top